[SYRE] YoY Quarter Result on 30-Jun-2021 [#Q2]

Stock
[SYRE] Spyre Therapeutics, Inc.
Announcement Date
28-Jun-2021
Financial Year
2021
Quarter
30-Jun-2021 [#Q2]
Profit Trend
QoQ- 62.51%
YoY- 68.11%
Quarter Report
SYRE's Result
SYRE's Financial Summary
View:
Show?
Quarter Result
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
Revenue 0 688 625 13,696 0 0 2,378 -
PBT -38,837 -217,074 -22,314 -6,738 -21,418 -18,019 -9,414 26.61%
Tax 0 7 9 92 0 0 0 -
NP -38,837 -217,081 -22,323 -6,830 -21,418 -18,019 -9,414 26.61%
Tax Rate - - - - - - - -
Total Cost 38,837 217,769 22,948 20,526 21,418 18,019 11,792 21.95%
Ratio Analysis
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
NP Margin 0.00 -31,552.47 -3,571.68 -49.87 0.00 0.00 -395.88 -
Per Share
30/06/24 30/06/23 30/06/22 30/06/21 30/06/20 30/06/19 30/06/18 CAGR
EPS -0.86 -56.79 -6.79 -2.60 -10.11 -13.72 -11.43 -35.00%
EPS Diluted -0.86 -56.79 -6.79 -2.60 -10.11 -13.72 -11.43 -35.00%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.